Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 4 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Toward better assessments of developmental toxicity using stem cell-based in vitro embryogenesis models.
Birth Defects Res. 2022 Oct 1;114(16):972-982. doi: 10.1002/bdr2.1984. Epub 2022 Jan 31.
Birth Defects Res. 2022.
PMID: 35102709
Free PMC article.
Review.
Remdesivir impairs mouse preimplantation embryo development at therapeutic concentrations.
Marikawa Y, Alarcon VB.
Marikawa Y, et al.
Reprod Toxicol. 2022 Aug;111:135-147. doi: 10.1016/j.reprotox.2022.05.012. Epub 2022 May 21.
Reprod Toxicol. 2022.
PMID: 35605700
Free PMC article.
Item in Clipboard
Gastruloids: Pluripotent stem cell models of mammalian gastrulation and embryo engineering.
Arias AM, Marikawa Y, Moris N.
Arias AM, et al.
Dev Biol. 2022 Aug;488:35-46. doi: 10.1016/j.ydbio.2022.05.002. Epub 2022 May 7.
Dev Biol. 2022.
PMID: 35537519
Free PMC article.
Item in Clipboard
Dolutegravir Impairs Stem Cell-Based 3D Morphogenesis Models in a Manner Dependent on Dose and Timing of Exposure: An Implication for Its Developmental Toxicity.
Kirkwood-Johnson L, Katayama N, Marikawa Y.
Kirkwood-Johnson L, et al.
Toxicol Sci. 2021 Nov 24;184(2):191-203. doi: 10.1093/toxsci/kfab112.
Toxicol Sci. 2021.
PMID: 34515794
Free PMC article.
Item in Clipboard
An active metabolite of the anti-COVID-19 drug molnupiravir impairs mouse preimplantation embryos at clinically relevant concentrations.
Marikawa Y, Alarcon VB.
Marikawa Y, et al.
Reprod Toxicol. 2023 Oct;121:108475. doi: 10.1016/j.reprotox.2023.108475. Epub 2023 Sep 23.
Reprod Toxicol. 2023.
PMID: 37748715
Item in Clipboard
Developmental toxicity of remdesivir, an anti-COVID-19 drug, is implicated by in vitro assays using morphogenetic embryoid bodies of mouse and human pluripotent stem cells.
Kirkwood-Johnson L, Marikawa Y.
Kirkwood-Johnson L, et al.
Birth Defects Res. 2023 Jan 15;115(2):224-239. doi: 10.1002/bdr2.2111. Epub 2022 Nov 8.
Birth Defects Res. 2023.
PMID: 36349436
Free PMC article.
Item in Clipboard
Cite
Cite